Meteorological effects on severe hemoptysis: A hospital-based observational study

Ogata, Hiroaki; Matsumoto, Koichiro; Shinozaki, Seiji; Hasegawa, Maki; Nakamura, Satoshi; Mizusaki, Shun; Takao, Tomoaki; Nakatomi, Keita; Nakashima, Naotoshi; Takahashi, Kohei; Soeda, Hiroyasu; Hanada, K.; Kojima, Hiroshi

doi:10.1016/j.resinv.2019.02.005

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Health-related quality of life (HRQoL) is defined as an individual's overall satisfaction with life and functional status in relation to disease [9]. Haemoptysis often occurs suddenly and without any prodromal symptoms, such as haemo-sputum [5,10]. Furthermore, patients with haemoptysis experience both acute and chronic decreases in terms of HRQoL [5,11,12].…”

Section: Introductionmentioning

confidence: 99%

The impact of bronchial artery embolisation on the quality of life of patients with haemoptysis: a prospective observational study

et al. 2021

View full text Add to dashboard Cite

Objectives Patients with haemoptysis often experience daily physical and mental impairment. Bronchial artery embolisation is among the first-line treatment options used worldwide; however, no evidence exists regarding the health-related quality of life (HRQoL) after bronchial artery embolisation. Therefore, this study aimed to evaluate the effects of bronchial artery embolisation on the HRQoL of patients with haemoptysis. Methods We prospectively enrolled 61 consecutive patients who visited our hospital from July 2017 to August 2018 and received bronchial artery embolisation for haemoptysis. The primary outcome was the HRQoL evaluated using the Short Form Health Survey, which contains physical and mental components, before and after bronchial artery embolisation. The secondary outcomes were procedural success, complications, and recurrence-free survival rate at 6 months. Results The mean age of the patients was 69 years (range, 31–87 years). The procedural success rate was 98%. No major complications occurred. The recurrence-free survival rate estimated using the Kaplan-Meier analysis at 6 months after bronchial artery embolisation was 91.8% (95% confidence interval, 91.1–92.5%). Compared with the pre-treatment scores, the physical and mental scores were significantly improved at 6 months after bronchial artery embolisation (p < 0.05). Conclusion Bronchial artery embolisation improved the HRQoL of patients with haemoptysis. Key Points • Bronchial artery embolisation improved the HRQoL of patients with haemoptysis. • Vessel dilation on computed tomography and systemic artery-pulmonary artery direct shunting on angiography were the most common abnormalities. • The recurrence-free survival rate estimated using the Kaplan-Meier analysis at 6 months after bronchial artery embolisation was 91.8%.

show abstract